Ajuste direto para aquisição de I1176 - Ivacaftor [150 mg; cáp/ comp]; I1177 - Ivacaftor + tezacaftor + elexacaftor [75 + 50 + 100 mg; cáp/ comp]; I1252 - Ivacaftor [75 mg; cáp/comp]; I1253 - Ivacaftor [75 mg;gran]; I1254 - Ivacaftor [50 mg;gran]; I1255 - Ivacaftor + tezacaftor + elexacaftor [37.5 mg + 25 mg + 50 mg;comp]; L1116 - Lumacaftor + ivacaftor [100 mg + 125 mg; cáp/ comp]; L1163 - Lumacaftor + ivacaftor [100 mg + 125 mg; gran; saqueta] e L1164 - Lumacaftor + ivacaftor [150 mg + 188 mg; gran; saqueta]

Contracting body

Unidade Local de Saúde de Santa Maria, E. P. E.

Awardee

VERTEX PHARMACEUTICALS (PORTUGAL), UNIPESSOAL LDA.

Place of performance

Portugal, Lisboa, Lisboa

NUTS region

Not stated

Contract price

€98,415.18

Procedure base price

€36,840,622.21

Total effective price

Not reported on Portal BASE

Publication date

2 April 2025

Award date

20 February 2025

Signing date

20 March 2025

Performance period

334 days

The contract price is the value agreed in the contract, not the amount paid.

Contract type

Aquisição de bens móveis

Procedure type

Direct award, general (Ajuste Direto Regime Geral)

Award criterion

Monofator

CPV code

33600000-6 - Produtos farmacêuticos

Legal basis

Artigo 24.º, n.º 1, alínea e), subalínea ii) do Código dos Contratos Públicos

Regime

Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05

Framework agreement

Not stated

Centralised procedure

Yes

Environmental criterion

No

Notice

Not stated

Procedure identifier

7448120